![](/wp-content/uploads/AMBA-logo-Acc-black.png"){kind=logo}
- The collaboration aims to contribute to the development and establishment of better health care delivery services
- Focus on research in new technology and management frontiers like Big Data, AI, SMM, etc.
IIM Indore aims to remain contextually relevant and take initiatives and measures to add to the betterment of the world we live in. The COVID19 pandemic has had an impact on every one of us. Not only the economy but every single sector right from manufacturing, hospitality, tourism, education, etc. have been affected by the massive outbreak of the pandemic. The healthcare sector has played a significant role since ever, especially in the last two years. The radical advancement in technology & research, and its adaptation by the healthcare, pharmaceutical and medicine industries has proved to be a boon. IIM Indore has stepped up once again to contribute to the betterment of society, this time in the healthcare sector; and has signed a Letter of Intent (LoI) with AstraZeneca Pharma India Limited. The LoI was signed by Prof. Himanshu Rai, Director, IIM Indore and Mr. Gagandeep Singh, Country President, AstraZeneca Pharma India Limited on October 12, 2021.
Prof. Himanshu Rai noted that the purpose of the LoI is to contribute to the expansion and establishment of better and robust healthcare delivery services through a mutual academic-industry partnership. ‘We at IIM Indore are always keen to contribute to improving the quality of life for people around us, and a big component of that is health. We are pledged to create a healthier India and hence, we are pleased to collaborate with AstraZeneca, for our support to the healthcare sector’, he said. He noted that the collaboration would focus on the joint use of research equipment and facilities for research in modern technology and management frontiers like Big Data Analytics, AI, Communication, GIS, Video Analytics, Knowledge & Information Management Systems and Lean and Agile Techniques. ‘We would also incorporate managerial aspects like Negotiation, Service Improvement, Social Media Management, Authentic and Inclusive Leadership Development, etc.’, he added.
Sharing his delight over collaboration with IIM Indore, Mr. Gagandeep Singh noted that IIM Indore is amongst the top B-Schools in India with a Triple Crown accreditation. ‘We are happy to sign a Letter of Intent with IIM Indore and join hands for research and projects with its talented faculty members. Apart from publishing research studies on mutually agreed topics, the collaboration also aims to review the existing identification, diagnostic and treatment regime in public health setup. We look forward to the recommendations from the IIM Indore team for further strengthening of the system’, he said.
IIM Indore and AstraZeneca would also work diligently for research and publications, conducting skill development and awareness programmes in the areas of public health, public health policy, public/private health organizations for improving access to health and innovation.
The collaboration is an umbrella of multiple projects with an objective to raise awareness about public health and health policies. A team led by Prof. Himanshu Rai, consisting Prof. Sneha Thapliyal & Prof. Sayantan Banerjee, Faculty, IIM Indore, would be working on these projects for the LoI valid for three years.